Sionna Therapeutics (SION) Change in Acquisitions & Divestments (2024 - 2026)

Sionna Therapeutics has disclosed Change in Acquisitions & Divestments across 3 years of filings, most recently posting $50.1 million for Q1 2026.

• Change in Acquisitions & Divestments for Q1 2026 came in at $50.1 million, up 64.49% year-over-year; the trailing twelve-month figure through Mar 2026 was $226.3 million (up 161.81% YoY), and the FY2025 annual result was $206.7 million, up 269.32% from the prior year.
• Change in Acquisitions & Divestments came in at $50.1 million for Q1 2026 at Sionna Therapeutics, down from $65.7 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $77.3 million in Q3 2025 to a low of $22.5 million in Q4 2024.
• The 3-year median for Change in Acquisitions & Divestments is $33.5 million (2024), against an average of $44.7 million.
• Across the five-year window, Change in Acquisitions & Divestments surged 192.45% in 2025 and soared 64.49% in 2026, its largest moves.
• Sionna Therapeutics' Change in Acquisitions & Divestments stood at $22.5 million in 2024, then soared by 192.45% to $65.7 million in 2025, then declined by 23.64% to $50.1 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $50.1 million (Q1 2026), $65.7 million (Q4 2025), and $77.3 million (Q3 2025), per Business Quant data.